The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered
intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is …

Background The coronavirus disease of 2019 (COVID‐19) is a global pandemic with over
266 million cases and 5 million deaths worldwide. Anti‐COVID‐19 vaccinations have had …

Background Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety. We report
six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. Methods …

Importance Vaccine-associated myocarditis is an unusual entity that has been described for
the smallpox vaccine, but only anecdotal case reports have been described for other …

Background Myocarditis following coronavirus disease 2019 (COVID-19) mRNA vaccines
(Pfizer-BioNTech and Moderna) has been increasingly reported. Incidence rates in the …

Myocarditis has been recognized as a rare complication of coronavirus disease 2019
(COVID-19) mRNA vaccinations, especially in young adult and adolescent males. According …

Myocarditis is recognized as a rare complication of coronavirus disease 2019 (COVID-19)
vaccinations, especially in young adult men and adolescent boys. 1, 2 Incidence is …

Background Association between messenger RNA (mRNA) COVID-19 vaccines and
myocarditis has aroused public concern over vaccine safety. Objectives The goal of this …

Introduction mRNA COVID-19 vaccines have emerged as a new form of vaccination that has
proven to be highly safe and effective against COVID-19 vaccination. Rare adverse events …

Background Reports have suggested an association between the development of
myocarditis and the receipt of messenger RNA (mRNA) vaccines against coronavirus …